Search - tctmd.com

Displaying 1 - 20 of 46

Sort: Relevancy | Date

News Industry News

New RE-VERSE AD™ Analyses Provide Additional Insights on Impact of Idarucizumab (Praxbind®) in Pradaxa® Patients with Gastrointestinal Bleeding or Needing Emergency Surgery

November 14, 2017

News Industry News

Amgen Announces Positive Top-Line Results From Phase 3 GLAGOV Imaging Study Of Repatha® (Evolocumab)

September 20, 2016

News Industry News

Meta-Analysis Shows Medtronic's Solitaire(TM) Stent Retriever Device Improves Functional Outcomes for Acute Ischemic Stroke Patients; Reduced Mortality in Patients 80+

February 17, 2016

News Industry News

Study Demonstrates i-cor® Synchronized Cardiac Assist Preserves Left Ventricular (LV) Function Compared to Continuous-Flow ECLS in Cardiogenic Shock

December 15, 2015

News Industry News

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

October 14, 2015

News Industry News

Medtronic Launches Arc(TM) Support Catheter Series in U.S. for Treatment of Acute Ischemic Stroke

September 17, 2015

News Industry News

Portola Pharmaceuticals Announces Second Part of Phase 3 ANNEXA(TM)-R Study: Andexanet Alfa and Rivaroxaban Meets Primary and Secondary Endpoints

September 16, 2015

News Industry News

Medicure Announces Filing of sNDA for New AGGRASTAT® Indication

September 10, 2015

News Industry News

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

September 03, 2015

News Industry News

American Heart Association's New Stroke Treatment Guidelines Establish Stent Retrievers as First-Line Endovascular Treatment for Acute Ischemic Stroke

June 30, 2015

News Industry News

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

June 19, 2015

News Industry News

New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years

May 19, 2015

News Industry News

Abiomed Impella 2.5 Receives FDA Approval for Elective and Urgent High Risk Percutaneous Coronary Intervention (PCI) Procedures

March 23, 2015

News Industry News

Medtronic CoreValve® System Sustains Superior Survival Benefit Over Open Heart Surgery at Two Years

March 15, 2015

News Industry News

Medtronic Initiates Trial Evaluating Cryoballoon for Early Persistent AF

February 02, 2015

News Industry News

New Data From EVOLVE Clinical Program Demonstrate SYNERGY™ Bioabsorbable Polymer Stent Meets Key Performance Endpoints

November 18, 2014

News Industry News

Boehringer Ingelheim Initiates U.S. Sites in First-Ever Global Phase III Trial of Investigational Antidote in Patients Taking PRADAXA®

November 09, 2014

News Industry News

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent Following CE Mark

November 02, 2014

News Industry News

The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease

October 10, 2014

News Industry News

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

September 23, 2014

Advertisement

New RE-VERSE AD™ Analyses Provide Additional Insights on Impact of Idarucizumab (Praxbind®) in Pradaxa® Patients with Gastrointestinal Bleeding or Needing Emergency Surgery

Amgen Announces Positive Top-Line Results From Phase 3 GLAGOV Imaging Study Of Repatha® (Evolocumab)

Meta-Analysis Shows Medtronic's Solitaire(TM) Stent Retriever Device Improves Functional Outcomes for Acute Ischemic Stroke Patients; Reduced Mortality in Patients 80+

Study Demonstrates i-cor® Synchronized Cardiac Assist Preserves Left Ventricular (LV) Function Compared to Continuous-Flow ECLS in Cardiogenic Shock

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

Medtronic Launches Arc(TM) Support Catheter Series in U.S. for Treatment of Acute Ischemic Stroke

Portola Pharmaceuticals Announces Second Part of Phase 3 ANNEXA(TM)-R Study: Andexanet Alfa and Rivaroxaban Meets Primary and Secondary Endpoints

Medicure Announces Filing of sNDA for New AGGRASTAT® Indication

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

American Heart Association's New Stroke Treatment Guidelines Establish Stent Retrievers as First-Line Endovascular Treatment for Acute Ischemic Stroke

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years

Abiomed Impella 2.5 Receives FDA Approval for Elective and Urgent High Risk Percutaneous Coronary Intervention (PCI) Procedures

Medtronic CoreValve® System Sustains Superior Survival Benefit Over Open Heart Surgery at Two Years

Medtronic Initiates Trial Evaluating Cryoballoon for Early Persistent AF

New Data From EVOLVE Clinical Program Demonstrate SYNERGY™ Bioabsorbable Polymer Stent Meets Key Performance Endpoints

Boehringer Ingelheim Initiates U.S. Sites in First-Ever Global Phase III Trial of Investigational Antidote in Patients Taking PRADAXA®

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent Following CE Mark

The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content